[Pulsed-dose rate brachytherapy in cervical cancers: why, how?]. / Curiethérapie de débit de dose pulsé dans les cancers du col utérin : pourquoi, comment ?
Cancer Radiother
; 18(5-6): 447-51, 2014 Oct.
Article
en Fr
| MEDLINE
| ID: mdl-25155782
ABSTRACT
The end of the production of 192 iridium wires terminates low dose rate brachytherapy and requires to move towards pulsed-dose rate or high-dose rate brachytherapy. In the case of gynecological cancers, technical alternatives exist, and many teams have already taken the step of pulsed-dose rate for scientific reasons. Using a projector source is indeed a prerequisite for 3D brachytherapy, which gradually installs as a standard treatment in the treatment of cervical cancers. For other centers, this change implies beyond investments in equipment and training, organizational consequences to ensure quality.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Contexto en salud:
1_ASSA2030
/
2_ODS3
Problema de salud:
1_doencas_nao_transmissiveis
/
2_muertes_prematuras_enfermedades_notrasmisibles
Asunto principal:
Braquiterapia
/
Neoplasias del Cuello Uterino
Tipo de estudio:
Etiology_studies
Límite:
Female
/
Humans
Idioma:
Fr
Revista:
Cancer Radiother
Asunto de la revista:
NEOPLASIAS
/
RADIOTERAPIA
Año:
2014
Tipo del documento:
Article